DNA synthesis
Telesis Bio to Raise up to $21M Through Private Stock Placement
The synthetic biology firm plans to use the money to drive adoption of its recently launched Gibson SOLA enzymatic synthesis technology.
Maravai LifeSciences Acquires IP, Assets From Shuttered Molecular Assemblies
Maravai will use the enzymatic DNA synthesis technology from Molecular Assemblies to enable customers to develop mRNA and CRISPR nucleic acid-based therapies.
Biomemory Raises $18M in Series A Financing to Develop Enzymatic DNA Data Storage Technology
The French company plans to further develop and commercialize its data storage technology by seeking industry collaborations and expanding its workforce.
Telesis Bio, Beckman Coulter Life Sciences Partner on DNA Synthesis Biofoundries
The deal brings together Telesis Bio's Gibson SOLA enzymatic DNA synthesis technology with Beckman Coulter's automation platform for rapid oligo production.
Evonetix Inks Deal With Analog Devices to Expand Thermally Controlled Enzymatic DNA Synthesis
The companies have signed a joint development and a commercial supply agreement to develop a semiconductor-based gene synthesis benchtop platform.